Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2024 20:48 ET | Source: Research and Markets

HIV Clinical Trials Market Poised for Accelerated Growth, Forecasts Reveal Steady Expansion with Notable CAGR Through 2030

Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational...
August 29, 2022 06:33 ET | Source: Research and Markets

Outlook on the HIV Clinical Trials Global Market to 2030 - Rising Drug Approvals and New Product Launches is Driving Growth

Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...
August 24, 2020 09:00 ET | Source: GeoVax, Inc.

GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients

ATLANTA, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
November 28, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Provides Update on HIV Clinical Trials Program

Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...